 | • レポートコード：MRC2-11QY03501 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はブルセラアボルタスワクチンのグローバル市場について調査・分析したレポートです。種類別（DNAワクチン、サブユニットワクチン、ベクターワクチン、B.中絶組換え変異体、その他）市場規模、用途別（牛、羊、豚、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ブルセラアボルタスワクチンの競争状況、市場シェア ・世界のブルセラアボルタスワクチン市場：種類別市場規模 2015年-2020年（DNAワクチン、サブユニットワクチン、ベクターワクチン、B.中絶組換え変異体、その他） ・世界のブルセラアボルタスワクチン市場：種類別市場規模予測 2021年-2026年（DNAワクチン、サブユニットワクチン、ベクターワクチン、B.中絶組換え変異体、その他） ・世界のブルセラアボルタスワクチン市場：用途別市場規模 2015年-2020年（牛、羊、豚、その他） ・世界のブルセラアボルタスワクチン市場：用途別市場規模予測 2021年-2026年（牛、羊、豚、その他） ・北米のブルセラアボルタスワクチン市場分析：米国、カナダ ・ヨーロッパのブルセラアボルタスワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのブルセラアボルタスワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のブルセラアボルタスワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのブルセラアボルタスワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Zoetis、CEVA、Merck Animal Health、Biovet、CAVAC、JOVAC、Merial、Colorado Serum Company、VECOL、Tecnovax、Indian Immunologicals、Vetal、Dollvet、Centro Diagnostico Veterinario、Onderstepoort Biological Products、Institute of Animal Health and Veterinary Biologicals、Biogenesis Bago、Instituto Rosenbusch、SYVA Laboratorios、CZ Veterinaria、Hester Biosciences、Qilu Animal Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Brucella Abortus Vaccine Market
The global Brucella Abortus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Brucella Abortus Vaccine Scope and Market Size
Brucella Abortus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brucella Abortus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Brucella Abortus Vaccine market is segmented into
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others
Segment by Application, the Brucella Abortus Vaccine market is segmented into
Cattles
Sheep
Pigs
Others
Regional and Country-level Analysis
The Brucella Abortus Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Brucella Abortus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Brucella Abortus Vaccine Market Share Analysis
Brucella Abortus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Brucella Abortus Vaccine business, the date to enter into the Brucella Abortus Vaccine market, Brucella Abortus Vaccine product introduction, recent developments, etc.
The major vendors covered:
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health
1 Study Coverage
1.1 Brucella Abortus Vaccine Product Introduction
1.2 Market Segments
1.3 Key Brucella Abortus Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Type
1.4.2 DNA Vaccines
1.4.3 Subunit Vaccines
1.4.4 Vector Vaccines
1.4.5 B. Abortus Recombinant Mutants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Application
1.5.2 Cattles
1.5.3 Sheep
1.5.4 Pigs
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Brucella Abortus Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Brucella Abortus Vaccine Revenue 2015-2026
2.1.2 Global Brucella Abortus Vaccine Sales 2015-2026
2.2 Global Brucella Abortus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Brucella Abortus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Brucella Abortus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Brucella Abortus Vaccine Competitor Landscape by Players
3.1 Brucella Abortus Vaccine Sales by Manufacturers
3.1.1 Brucella Abortus Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Brucella Abortus Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Brucella Abortus Vaccine Revenue by Manufacturers
3.2.1 Brucella Abortus Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Brucella Abortus Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Brucella Abortus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Brucella Abortus Vaccine Revenue in 2019
3.2.5 Global Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Brucella Abortus Vaccine Price by Manufacturers
3.4 Brucella Abortus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Brucella Abortus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Brucella Abortus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Brucella Abortus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brucella Abortus Vaccine Market Size by Type (2015-2020)
4.1.1 Global Brucella Abortus Vaccine Sales by Type (2015-2020)
4.1.2 Global Brucella Abortus Vaccine Revenue by Type (2015-2020)
4.1.3 Brucella Abortus Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Brucella Abortus Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Brucella Abortus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Brucella Abortus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Brucella Abortus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Brucella Abortus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Brucella Abortus Vaccine Market Size by Application (2015-2020)
5.1.1 Global Brucella Abortus Vaccine Sales by Application (2015-2020)
5.1.2 Global Brucella Abortus Vaccine Revenue by Application (2015-2020)
5.1.3 Brucella Abortus Vaccine Price by Application (2015-2020)
5.2 Brucella Abortus Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Brucella Abortus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Brucella Abortus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Brucella Abortus Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Brucella Abortus Vaccine by Country
6.1.1 North America Brucella Abortus Vaccine Sales by Country
6.1.2 North America Brucella Abortus Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Brucella Abortus Vaccine Market Facts & Figures by Type
6.3 North America Brucella Abortus Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Brucella Abortus Vaccine by Country
7.1.1 Europe Brucella Abortus Vaccine Sales by Country
7.1.2 Europe Brucella Abortus Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Brucella Abortus Vaccine Market Facts & Figures by Type
7.3 Europe Brucella Abortus Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Brucella Abortus Vaccine by Region
8.1.1 Asia Pacific Brucella Abortus Vaccine Sales by Region
8.1.2 Asia Pacific Brucella Abortus Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Brucella Abortus Vaccine by Country
9.1.1 Latin America Brucella Abortus Vaccine Sales by Country
9.1.2 Latin America Brucella Abortus Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Brucella Abortus Vaccine Market Facts & Figures by Type
9.3 Central & South America Brucella Abortus Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Brucella Abortus Vaccine by Country
10.1.1 Middle East and Africa Brucella Abortus Vaccine Sales by Country
10.1.2 Middle East and Africa Brucella Abortus Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Brucella Abortus Vaccine Products Offered
11.1.5 Zoetis Related Developments
11.2 CEVA
11.2.1 CEVA Corporation Information
11.2.2 CEVA Description and Business Overview
11.2.3 CEVA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CEVA Brucella Abortus Vaccine Products Offered
11.2.5 CEVA Related Developments
11.3 Merck Animal Health
11.3.1 Merck Animal Health Corporation Information
11.3.2 Merck Animal Health Description and Business Overview
11.3.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Animal Health Brucella Abortus Vaccine Products Offered
11.3.5 Merck Animal Health Related Developments
11.4 Biovet
11.4.1 Biovet Corporation Information
11.4.2 Biovet Description and Business Overview
11.4.3 Biovet Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biovet Brucella Abortus Vaccine Products Offered
11.4.5 Biovet Related Developments
11.5 CAVAC
11.5.1 CAVAC Corporation Information
11.5.2 CAVAC Description and Business Overview
11.5.3 CAVAC Sales, Revenue and Gross Margin (2015-2020)
11.5.4 CAVAC Brucella Abortus Vaccine Products Offered
11.5.5 CAVAC Related Developments
11.6 JOVAC
11.6.1 JOVAC Corporation Information
11.6.2 JOVAC Description and Business Overview
11.6.3 JOVAC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 JOVAC Brucella Abortus Vaccine Products Offered
11.6.5 JOVAC Related Developments
11.7 Merial
11.7.1 Merial Corporation Information
11.7.2 Merial Description and Business Overview
11.7.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merial Brucella Abortus Vaccine Products Offered
11.7.5 Merial Related Developments
11.8 Colorado Serum Company
11.8.1 Colorado Serum Company Corporation Information
11.8.2 Colorado Serum Company Description and Business Overview
11.8.3 Colorado Serum Company Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Colorado Serum Company Brucella Abortus Vaccine Products Offered
11.8.5 Colorado Serum Company Related Developments
11.9 VECOL
11.9.1 VECOL Corporation Information
11.9.2 VECOL Description and Business Overview
11.9.3 VECOL Sales, Revenue and Gross Margin (2015-2020)
11.9.4 VECOL Brucella Abortus Vaccine Products Offered
11.9.5 VECOL Related Developments
11.10 Tecnovax
11.10.1 Tecnovax Corporation Information
11.10.2 Tecnovax Description and Business Overview
11.10.3 Tecnovax Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tecnovax Brucella Abortus Vaccine Products Offered
11.10.5 Tecnovax Related Developments
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Brucella Abortus Vaccine Products Offered
11.1.5 Zoetis Related Developments
11.12 Vetal
11.12.1 Vetal Corporation Information
11.12.2 Vetal Description and Business Overview
11.12.3 Vetal Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Vetal Products Offered
11.12.5 Vetal Related Developments
11.13 Dollvet
11.13.1 Dollvet Corporation Information
11.13.2 Dollvet Description and Business Overview
11.13.3 Dollvet Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Dollvet Products Offered
11.13.5 Dollvet Related Developments
11.14 Centro Diagnostico Veterinario
11.14.1 Centro Diagnostico Veterinario Corporation Information
11.14.2 Centro Diagnostico Veterinario Description and Business Overview
11.14.3 Centro Diagnostico Veterinario Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Centro Diagnostico Veterinario Products Offered
11.14.5 Centro Diagnostico Veterinario Related Developments
11.15 Onderstepoort Biological Products
11.15.1 Onderstepoort Biological Products Corporation Information
11.15.2 Onderstepoort Biological Products Description and Business Overview
11.15.3 Onderstepoort Biological Products Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Onderstepoort Biological Products Products Offered
11.15.5 Onderstepoort Biological Products Related Developments
11.16 Institute of Animal Health and Veterinary Biologicals
11.16.1 Institute of Animal Health and Veterinary Biologicals Corporation Information
11.16.2 Institute of Animal Health and Veterinary Biologicals Description and Business Overview
11.16.3 Institute of Animal Health and Veterinary Biologicals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Institute of Animal Health and Veterinary Biologicals Products Offered
11.16.5 Institute of Animal Health and Veterinary Biologicals Related Developments
11.17 Biogenesis Bago
11.17.1 Biogenesis Bago Corporation Information
11.17.2 Biogenesis Bago Description and Business Overview
11.17.3 Biogenesis Bago Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Biogenesis Bago Products Offered
11.17.5 Biogenesis Bago Related Developments
11.18 Instituto Rosenbusch
11.18.1 Instituto Rosenbusch Corporation Information
11.18.2 Instituto Rosenbusch Description and Business Overview
11.18.3 Instituto Rosenbusch Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Instituto Rosenbusch Products Offered
11.18.5 Instituto Rosenbusch Related Developments
11.19 SYVA Laboratorios
11.19.1 SYVA Laboratorios Corporation Information
11.19.2 SYVA Laboratorios Description and Business Overview
11.19.3 SYVA Laboratorios Sales, Revenue and Gross Margin (2015-2020)
11.19.4 SYVA Laboratorios Products Offered
11.19.5 SYVA Laboratorios Related Developments
11.20 CZ Veterinaria
11.20.1 CZ Veterinaria Corporation Information
11.20.2 CZ Veterinaria Description and Business Overview
11.20.3 CZ Veterinaria Sales, Revenue and Gross Margin (2015-2020)
11.20.4 CZ Veterinaria Products Offered
11.20.5 CZ Veterinaria Related Developments
11.21 Hester Biosciences
11.21.1 Hester Biosciences Corporation Information
11.21.2 Hester Biosciences Description and Business Overview
11.21.3 Hester Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Hester Biosciences Products Offered
11.21.5 Hester Biosciences Related Developments
11.22 Qilu Animal Health
11.22.1 Qilu Animal Health Corporation Information
11.22.2 Qilu Animal Health Description and Business Overview
11.22.3 Qilu Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Qilu Animal Health Products Offered
11.22.5 Qilu Animal Health Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Brucella Abortus Vaccine Market Estimates and Projections by Region
12.1.1 Global Brucella Abortus Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Brucella Abortus Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Brucella Abortus Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Brucella Abortus Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Brucella Abortus Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Brucella Abortus Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Brucella Abortus Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Brucella Abortus Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Brucella Abortus Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Brucella Abortus Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Brucella Abortus Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Brucella Abortus Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Brucella Abortus Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Brucella Abortus Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Brucella Abortus Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Brucella Abortus Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Brucella Abortus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Brucella Abortus Vaccine Market Segments
Table 2. Ranking of Global Top Brucella Abortus Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Brucella Abortus Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of DNA Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Vector Vaccines
Table 7. Major Manufacturers of B. Abortus Recombinant Mutants
Table 8. Major Manufacturers of Others
Table 9. Global Brucella Abortus Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Brucella Abortus Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Brucella Abortus Vaccine Sales by Regions 2015-2020 (K Units)
Table 12. Global Brucella Abortus Vaccine Sales Market Share by Regions (2015-2020)
Table 13. Global Brucella Abortus Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Brucella Abortus Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Brucella Abortus Vaccine Sales Share by Manufacturers (2015-2020)
Table 16. Global Brucella Abortus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Brucella Abortus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucella Abortus Vaccine as of 2019)
Table 18. Brucella Abortus Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Brucella Abortus Vaccine Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Brucella Abortus Vaccine Price (2015-2020) (USD/Unit)
Table 21. Brucella Abortus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Brucella Abortus Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Brucella Abortus Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Brucella Abortus Vaccine Sales by Type (2015-2020) (K Units)
Table 26. Global Brucella Abortus Vaccine Sales Share by Type (2015-2020)
Table 27. Global Brucella Abortus Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Brucella Abortus Vaccine Revenue Share by Type (2015-2020)
Table 29. Brucella Abortus Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Brucella Abortus Vaccine Sales by Application (2015-2020) (K Units)
Table 31. Global Brucella Abortus Vaccine Sales Share by Application (2015-2020)
Table 32. North America Brucella Abortus Vaccine Sales by Country (2015-2020) (K Units)
Table 33. North America Brucella Abortus Vaccine Sales Market Share by Country (2015-2020)
Table 34. North America Brucella Abortus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Brucella Abortus Vaccine Revenue Market Share by Country (2015-2020)
Table 36. North America Brucella Abortus Vaccine Sales by Type (2015-2020) (K Units)
Table 37. North America Brucella Abortus Vaccine Sales Market Share by Type (2015-2020)
Table 38. North America Brucella Abortus Vaccine Sales by Application (2015-2020) (K Units)
Table 39. North America Brucella Abortus Vaccine Sales Market Share by Application (2015-2020)
Table 40. Europe Brucella Abortus Vaccine Sales by Country (2015-2020) (K Units)
Table 41. Europe Brucella Abortus Vaccine Sales Market Share by Country (2015-2020)
Table 42. Europe Brucella Abortus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2015-2020)
Table 44. Europe Brucella Abortus Vaccine Sales by Type (2015-2020) (K Units)
Table 45. Europe Brucella Abortus Vaccine Sales Market Share by Type (2015-2020)
Table 46. Europe Brucella Abortus Vaccine Sales by Application (2015-2020) (K Units)
Table 47. Europe Brucella Abortus Vaccine Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Brucella Abortus Vaccine Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Brucella Abortus Vaccine Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Brucella Abortus Vaccine Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Application (2015-2020)
Table 56. Latin America Brucella Abortus Vaccine Sales by Country (2015-2020) (K Units)
Table 57. Latin America Brucella Abortus Vaccine Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Brucella Abortus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Brucella Abortus Vaccine Revenue Market Share by Country (2015-2020)
Table 60. Latin America Brucella Abortus Vaccine Sales by Type (2015-2020) (K Units)
Table 61. Latin America Brucella Abortus Vaccine Sales Market Share by Type (2015-2020)
Table 62. Latin America Brucella Abortus Vaccine Sales by Application (2015-2020) (K Units)
Table 63. Latin America Brucella Abortus Vaccine Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Brucella Abortus Vaccine Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Brucella Abortus Vaccine Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Application (2015-2020)
Table 72. Zoetis Corporation Information
Table 73. Zoetis Description and Major Businesses
Table 74. Zoetis Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Zoetis Product
Table 76. Zoetis Recent Development
Table 77. CEVA Corporation Information
Table 78. CEVA Description and Major Businesses
Table 79. CEVA Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. CEVA Product
Table 81. CEVA Recent Development
Table 82. Merck Animal Health Corporation Information
Table 83. Merck Animal Health Description and Major Businesses
Table 84. Merck Animal Health Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Merck Animal Health Product
Table 86. Merck Animal Health Recent Development
Table 87. Biovet Corporation Information
Table 88. Biovet Description and Major Businesses
Table 89. Biovet Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Biovet Product
Table 91. Biovet Recent Development
Table 92. CAVAC Corporation Information
Table 93. CAVAC Description and Major Businesses
Table 94. CAVAC Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. CAVAC Product
Table 96. CAVAC Recent Development
Table 97. JOVAC Corporation Information
Table 98. JOVAC Description and Major Businesses
Table 99. JOVAC Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. JOVAC Product
Table 101. JOVAC Recent Development
Table 102. Merial Corporation Information
Table 103. Merial Description and Major Businesses
Table 104. Merial Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Merial Product
Table 106. Merial Recent Development
Table 107. Colorado Serum Company Corporation Information
Table 108. Colorado Serum Company Description and Major Businesses
Table 109. Colorado Serum Company Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Colorado Serum Company Product
Table 111. Colorado Serum Company Recent Development
Table 112. VECOL Corporation Information
Table 113. VECOL Description and Major Businesses
Table 114. VECOL Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. VECOL Product
Table 116. VECOL Recent Development
Table 117. Tecnovax Corporation Information
Table 118. Tecnovax Description and Major Businesses
Table 119. Tecnovax Brucella Abortus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Tecnovax Product
Table 121. Tecnovax Recent Development
Table 122. Indian Immunologicals Corporation Information
Table 123. Indian Immunologicals Description and Major Businesses
Table 124. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Indian Immunologicals Product
Table 126. Indian Immunologicals Recent Development
Table 127. Vetal Corporation Information
Table 128. Vetal Description and Major Businesses
Table 129. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Vetal Product
Table 131. Vetal Recent Development
Table 132. Dollvet Corporation Information
Table 133. Dollvet Description and Major Businesses
Table 134. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Dollvet Product
Table 136. Dollvet Recent Development
Table 137. Centro Diagnostico Veterinario Corporation Information
Table 138. Centro Diagnostico Veterinario Description and Major Businesses
Table 139. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Centro Diagnostico Veterinario Product
Table 141. Centro Diagnostico Veterinario Recent Development
Table 142. Onderstepoort Biological Products Corporation Information
Table 143. Onderstepoort Biological Products Description and Major Businesses
Table 144. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 145. Onderstepoort Biological Products Product
Table 146. Onderstepoort Biological Products Recent Development
Table 147. Institute of Animal Health and Veterinary Biologicals Corporation Information
Table 148. Institute of Animal Health and Veterinary Biologicals Description and Major Businesses
Table 149. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 150. Institute of Animal Health and Veterinary Biologicals Product
Table 151. Institute of Animal Health and Veterinary Biologicals Recent Development
Table 152. Biogenesis Bago Corporation Information
Table 153. Biogenesis Bago Description and Major Businesses
Table 154. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 155. Biogenesis Bago Product
Table 156. Biogenesis Bago Recent Development
Table 157. Instituto Rosenbusch Corporation Information
Table 158. Instituto Rosenbusch Description and Major Businesses
Table 159. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 160. Instituto Rosenbusch Product
Table 161. Instituto Rosenbusch Recent Development
Table 162. SYVA Laboratorios Corporation Information
Table 163. SYVA Laboratorios Description and Major Businesses
Table 164. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 165. SYVA Laboratorios Product
Table 166. SYVA Laboratorios Recent Development
Table 167. CZ Veterinaria Corporation Information
Table 168. CZ Veterinaria Description and Major Businesses
Table 169. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 170. CZ Veterinaria Product
Table 171. CZ Veterinaria Recent Development
Table 172. Hester Biosciences Corporation Information
Table 173. Hester Biosciences Description and Major Businesses
Table 174. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 175. Hester Biosciences Product
Table 176. Hester Biosciences Recent Development
Table 177. Qilu Animal Health Corporation Information
Table 178. Qilu Animal Health Description and Major Businesses
Table 179. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 180. Qilu Animal Health Product
Table 181. Qilu Animal Health Recent Development
Table 182. Global Brucella Abortus Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 183. Global Brucella Abortus Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 184. Global Brucella Abortus Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 185. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 186. North America: Brucella Abortus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 187. North America: Brucella Abortus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 188. Europe: Brucella Abortus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 189. Europe: Brucella Abortus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 190. Asia Pacific: Brucella Abortus Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 191. Asia Pacific: Brucella Abortus Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 192. Latin America: Brucella Abortus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 193. Latin America: Brucella Abortus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 194. Middle East and Africa: Brucella Abortus Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 195. Middle East and Africa: Brucella Abortus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 196. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 197. Key Challenges
Table 198. Market Risks
Table 199. Main Points Interviewed from Key Brucella Abortus Vaccine Players
Table 200. Brucella Abortus Vaccine Customers List
Table 201. Brucella Abortus Vaccine Distributors List
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucella Abortus Vaccine Product Picture
Figure 2. Global Brucella Abortus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. DNA Vaccines Product Picture
Figure 4. Subunit Vaccines Product Picture
Figure 5. Vector Vaccines Product Picture
Figure 6. B. Abortus Recombinant Mutants Product Picture
Figure 7. Others Product Picture
Figure 8. Global Brucella Abortus Vaccine Sales Market Share by Application in 2020 & 2026
Figure 9. Cattles
Figure 10. Sheep
Figure 11. Pigs
Figure 12. Others
Figure 13. Brucella Abortus Vaccine Report Years Considered
Figure 14. Global Brucella Abortus Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Brucella Abortus Vaccine Sales 2015-2026 (K Units)
Figure 16. Global Brucella Abortus Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Brucella Abortus Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Brucella Abortus Vaccine Sales Market Share by Region in 2019
Figure 19. Global Brucella Abortus Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Brucella Abortus Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Brucella Abortus Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Brucella Abortus Vaccine Revenue in 2019
Figure 23. Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Brucella Abortus Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Brucella Abortus Vaccine Sales Market Share by Type in 2019
Figure 26. Global Brucella Abortus Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Brucella Abortus Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Brucella Abortus Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Brucella Abortus Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Brucella Abortus Vaccine Sales Market Share by Application in 2019
Figure 31. Global Brucella Abortus Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Brucella Abortus Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Brucella Abortus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Brucella Abortus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Brucella Abortus Vaccine Sales Market Share by Country in 2019
Figure 36. North America Brucella Abortus Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Brucella Abortus Vaccine Market Share by Type in 2019
Figure 42. North America Brucella Abortus Vaccine Market Share by Application in 2019
Figure 43. Europe Brucella Abortus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Brucella Abortus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Brucella Abortus Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Brucella Abortus Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Brucella Abortus Vaccine Market Share by Type in 2019
Figure 58. Europe Brucella Abortus Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Brucella Abortus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Brucella Abortus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Region in 2019
Figure 63. China Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Brucella Abortus Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Brucella Abortus Vaccine Market Share by Application in 2019
Figure 87. Latin America Brucella Abortus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Brucella Abortus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Brucella Abortus Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Brucella Abortus Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Brucella Abortus Vaccine Market Share by Type in 2019
Figure 98. Latin America Brucella Abortus Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Brucella Abortus Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Brucella Abortus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Brucella Abortus Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Brucella Abortus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Brucella Abortus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Brucella Abortus Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Brucella Abortus Vaccine Market Share by Application in 2019
Figure 111. North America Brucella Abortus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Brucella Abortus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Brucella Abortus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Brucella Abortus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Brucella Abortus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Brucella Abortus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Brucella Abortus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Brucella Abortus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Brucella Abortus Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Brucella Abortus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
動物用ワクチンの世界市場（～2026年） Animal Vaccine is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. The major factors driving the growth of this market include growth in livestock population and repeated breakouts of livestock diseases; incre…- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 口蹄疫（FMD）ワクチンの世界市場（～2026年） An drug that provide immunity to the FMD. Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally. Livestock and zoonotic diseases are increasing over the past few decades owing to factors such a…
- がんワクチン薬剤用パイプラインの世界市場（～2026年） Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. Market Analysis and Insights: Global Cancer Vaccines Drug Pipeline Mark…
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…